
CVET
Healthcare · Health Care Providers & Services · $2.94B market cap
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2022
EPS trend, 90 days to now · 0.0% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Aug 4, 2022 | Before the open | 0.25 | 0.25 | 0.0% |
| May 5, 2022 | After the close | 0.22 | 0.25 | +13.6% |
| Feb 24, 2022 | After the close | 0.25 | 0.26 | +4.0% |
| Nov 4, 2021 | After the close | 0.23 | 0.23 | 0.0% |
| Aug 5, 2021 | After the close | 0.24 | 0.26 | +8.3% |
| May 6, 2021 | After the close | 0.17 | 0.21 | +23.5% |
| Mar 1, 2021 | Before the open | 0.16 | 0.21 | +31.3% |
| Nov 10, 2020 | After the close | 0.18 | 0.26 | +44.4% |
| Aug 11, 2020 | After the close | 0.08 | 0.27 | +237.5% |
| May 14, 2020 | After the close | 0.12 | 0.18 | +50.0% |
| Mar 3, 2020 | After the close | 0.12 | 0.18 | +50.0% |
| Nov 12, 2019 | Before the open | 0.07 | 0.17 | +142.9% |
| Aug 13, 2019 | Before the open | 0.16 | 0.13 | -18.8% |
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products,…
| May 15, 2019 | Before the open | 0.17 | 0.13 | -23.5% |
| Feb 7, 2019 | After the close | 0.13 | 1.73 | +1230.8% |
| Nov 1, 2018 | Time not confirmed | — | 0.46 | — |